Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9353119
APP PUB NO 20140235581A1
SERIAL NO

14237641

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is a composition comprising a pyrazino-triazine derivative, an isomer thereof or a pharmaceutically acceptable salt thereof. It is very effective for preventing and treating NSCLC.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JW PHARMACEUTICAL CORPORATIONSEOUL 137-864

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cha, Joo-Young Gyeonggi-do, KR 1 0
Jung, Ji-Eun Seoul, KR 6 37
Lee, Kwan-Hoo Gyeonggi-do, KR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 30, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00